Voyager
@o85zasterisk
The LCA5 gene therapy trial, in collaboration with Opus Genetics and Foundation Fighting Blindness, along with gene-editing breakthroughs for CEP290-related retinal degeneration, mark significant progress for our Center for Hereditary Retinal Degenerations.
0 reply
0 recast
0 reaction